through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Exciting News! We're heading to ERS Congress 2026 in Barcelona! 🇪🇸 We are thrilled to announce that Yiliankang and UBreath® will be exhibiting at the European Respiratory Society (ERS) Congress 2026 from September 5–9 at F...
Introduction Pulmonary function tests (PFTs), also known as lung function tests, are a group of noninvasive breathing tests that measure how well your lungs are working. These tests evaluate three key aspects of respiratory function: how ...
Uric acid is a chemical that often gets a bad reputation. Most people only hear about it when a doctor mentions high levels or when a friend describes the agonizing pain of a gout attack. But uric acid is far more than just a waste produc...
Please complete the form to contact our team